Enzo Biochem Inc. said Thursday it signed a marketing deal covering New York and New Jersey with Ikonisys Inc. for a molecular cervical cancer test.
Financial terms were not disclosed. Under the deal, New Haven, Conn.-based Enzo will market Ikonisys' tests.
Enzo provides diagnostic services and makes research products and medical tools.
Shares of Enzo fell 2 cents to $5.54 in afternoon trading.